GlassScriptPhysician profile
Kelsey J Webb
NPI 1407952336
$1,638.87
in general payments reported to CMS, 2019-2025
18 companies · $252 in 2025
The $252 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.72 · 2020: $129 · 2021: $263 · 2022: $230 · 2023: $568 · 2024: $111 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $688 · Travel and Lodging: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $687.58 |
| Travel and Lodging | $243.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $400.78 | 2023 | Altis |
| Abbvie INC. | $341.35 | 2019-2025 | Liletta, Lo Loestrin Fe, Orilissa |
| Pfizer INC. | $163.76 | 2020-2023 | |
| Hologic Sales and Service, LLC | $117.23 | 2019-2024 | Aptima |
| Intuitive Surgical, INC. | $115.06 | 2025 | |
| Sumitomo Pharma America, INC. | $80.60 | 2024-2025 | Myfembree |
| Astellas Pharma US INC | $70.09 | 2024 | Veozah |
| Merck Sharp & Dohme LLC | $55.33 | 2019-2021 | |
| Evofem Biosciences, INC. | $50.33 | 2021 | |
| Exeltis, USA INC. | $49.88 | 2022-2025 | Slynd |
| Mayne Pharma Commercial LLC | $44.69 | 2021-2022 | |
| Therapeuticsmd, INC. | $35.63 | 2019-2022 | |
| Mylan Pharmaceuticals INC. | $33.80 | 2020-2022 | |
| Sage Therapeutics, LLC | $19.64 | 2025 | Zurzuvae |
| Amgen INC. | $16.27 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $16.08 | 2020 | |
| Minerva Surgical, INC | $14.89 | 2025 | |
| Currax Pharmaceuticals LLC | $13.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelsey Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.